Uromigos Live-Kidney Cancer

Advertisement
The UromigosUromigos Live 2024 | September 28, 2024
Listen to the podcast format of the kidney cancer panel on TKI vs Ipi/Nivo vs IO/TKI from Uromigos Live 2024.
Listen Now
The UromigosThe Uromigos | September 23, 2024
Katy Beckermann discusses the TiNivo-2 study presented at ESMO 2024.
Hedyeh Ebrahimi, MD, MPHUromigos Live 2023 | November 8, 2023
Dr. Hedyeh Ebrahimi of City of Hope describes her favorite presentations and discussions related to renal cell carcinoma.
The UromigosUromigos Live and Unplugged | November 11, 2022
Sumanta Pal, MD, FASCO, from City of Hope talks about new drugs and the ongoing TiNivo-2 trial for renal cell carcinoma.
The UromigosUromigos Live and Unplugged | November 11, 2022
David McDermott, MD talks about monotherapy and combination therapy for RCC and future advances in RCC treatment.
The UromigosUromigos Live and Unplugged | November 10, 2022
Tian Zhang gives a quick recap of the Frontline Therapy in RCC panel from The Uromigos Live & Unplugged.
The UromigosUromigos Live and Unplugged | November 10, 2022
Axel Bex gives a quick recap of the renal panel on adjuvant therapy in RCC from The Uromigos Live & Unplugged.
The UromigosUromigos Live and Unplugged | November 10, 2022
The Uromigos and a panel of RCC experts discuss data on perioperative therapy in RCC, and the next adjuvant therapy trials.
The UromigosUromigos Live and Unplugged | November 10, 2022
A panel of RCC experts discuss frontline therapy for kidney cancer, as well as where they see it headed in the next 5 years.
Advertisement
Advertisement
Advertisement